Page last updated: 2024-09-03
kn 04 and calmidazolium
kn 04 has been researched along with calmidazolium in 1 studies
Compound Research Comparison
| Studies (kn 04) | Trials (kn 04) | Recent Studies (post-2010) (kn 04) | Studies (calmidazolium) | Trials (calmidazolium) | Recent Studies (post-2010) (calmidazolium) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 550 | 0 | 39 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chessell, IP; Humphrey, PP; Kaur, R; Michel, AD | 1 |
Other Studies
1 other study(ies) available for kn 04 and calmidazolium
| Article | Year |
|---|---|
Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Antibodies, Blocking; Benzoxazoles; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Enzyme Inhibitors; Fluorescent Dyes; Humans; Imidazoles; In Vitro Techniques; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Receptors, Purinergic P2X7; Stimulation, Chemical | 2000 |